Skip to main content
NCBI home page
Gut logoLink to Gut
. 1993 Aug;34(8):1042–1046. doi: 10.1136/gut.34.8.1042

Acid, motility, and ulcers: a comparison of cisapride with placebo in the prevention of duodenal ulcer relapse.

D D Kerrigan 1, M E Taylor 1, N W Read 1, A G Johnson 1
PMCID: PMC1374350  PMID: 8174950

Abstract

In a single centre double blind study of 66 patients, the value of cisapride (10 mg twice daily) was compared with placebo in the prevention of duodenal ulcer relapse. Patients who remained ulcer free attended for clinical review every two months and had a mandatory endoscopy at 0, 4, 8, and 12 months or if symptoms suggestive of ulcer recurrence developed. The 12 month crude relapse rates (that underestimate the probability of ulcer recurrence) showed that cisapride was superior to placebo (34% (11/32) relapsed on cisapride v 68% (23/34) on placebo, p = 0.007). This finding was confirmed using lifetable analysis, with a 35% reduction (95% confidence intervals 10-59%, p < 0.05) in the proportion of ulcer relapses in patients who had received cisapride compared with those treated with placebo. These results are similar to those reported in maintenance trials of H2 receptor antagonists analysed by the same method. Drug related adverse clinical events were mainly trivial, but led to three patients on cisapride and one on placebo withdrawing from the trial.

Full text

PDF
1042

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alstead E. M., Ryan F. P., Holdsworth C. D., Ashton M. G., Moore M. Ranitidine in the prevention of gastric and duodenal ulcer relapse. Gut. 1983 May;24(5):418–420. doi: 10.1136/gut.24.5.418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bardhan K. D., Hinchliffe R. F., Bose K. Low dose maintenance treatment with cimetidine in duodenal ulcer: intermediate-term results. Postgrad Med J. 1986 May;62(727):347–351. doi: 10.1136/pgmj.62.727.347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bodemar G., Walan A. Maintenance treatment of recurrent peptic ulcer by cimetidine. Lancet. 1978 Feb 25;1(8061):403–407. doi: 10.1016/s0140-6736(78)91200-x. [DOI] [PubMed] [Google Scholar]
  4. Boyd E. J., Penston J. G., Johnston D. A., Wormsley K. G. Does maintenance therapy keep duodenal ulcers healed? Lancet. 1988 Jun 11;1(8598):1324–1327. doi: 10.1016/s0140-6736(88)92131-9. [DOI] [PubMed] [Google Scholar]
  5. Boyd E. J., Wilson J. A., Wormsley K. G. Effects of treatment compliance and overnight gastric secretion on outcome of maintenance therapy of duodenal ulcer with ranitidine. Scand J Gastroenterol. 1983 Mar;18(2):193–200. doi: 10.3109/00365528309181583. [DOI] [PubMed] [Google Scholar]
  6. Boyd E. J., Wilson J. A., Wormsley K. G. Safety of ranitidine maintenance treatment of duodenal ulcer. Scand J Gastroenterol. 1984 May;19(3):394–400. [PubMed] [Google Scholar]
  7. Boyd E. J., Wilson J. A., Wormsley K. G. The fate of asymptomatic recurrences of duodenal ulcer. Scand J Gastroenterol. 1984 Sep;19(6):808–812. [PubMed] [Google Scholar]
  8. Bresci G., Capria A., Federici G., Rindi G., Geloni M., Corsini G. Prevention of relapse with various antiulcer drugs. Scand J Gastroenterol Suppl. 1986;121:58–62. doi: 10.3109/00365528609091680. [DOI] [PubMed] [Google Scholar]
  9. Camilleri M., Brown M. L., Malagelada J. R. Impaired transit of chyme in chronic intestinal pseudoobstruction. Correction by cisapride. Gastroenterology. 1986 Sep;91(3):619–626. doi: 10.1016/0016-5085(86)90631-1. [DOI] [PubMed] [Google Scholar]
  10. Coremans G., Janssens J., Vantrappen G., Chaussade S., Ceccatelli P. Cisapride stimulates propulsive motility patterns in human jejunum. Dig Dis Sci. 1988 Dec;33(12):1512–1519. doi: 10.1007/BF01535939. [DOI] [PubMed] [Google Scholar]
  11. Corinaldesi R., Stanghellini V., Raiti C., Rea E., Salgemini R., Barbara L. Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis. Gut. 1987 Mar;28(3):300–305. doi: 10.1136/gut.28.3.300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Drury J. K., McKay A. J., Hutchison J. S., Joffe S. N. Natural history of perforated duodenal ulcers treated by suture closure. Lancet. 1978 Oct 7;2(8093):749–750. doi: 10.1016/s0140-6736(78)92643-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Freston J. W. H2-receptor antagonists and duodenal ulcer recurrence: analysis of efficacy and commentary on safety, costs, and patient selection. Am J Gastroenterol. 1987 Dec;82(12):1242–1249. [PubMed] [Google Scholar]
  14. Ghigliani M., Iantorno G., Vázquez S., Varela A. Acute effect of the gastrokinetics cisapride and metoclopramide on the gastric emptying function in patients with the early satiety syndrome. Acta Gastroenterol Latinoam. 1987;17(1):43–50. [PubMed] [Google Scholar]
  15. Gough K. R., Korman M. G., Bardhan K. D., Lee F. I., Crowe J. P., Reed P. I., Smith R. N. Ranitidine and cimetidine in prevention of duodenal ulcer relapse. A double-blind, randomised, multicentre, comparative trial. Lancet. 1984 Sep 22;2(8404):659–662. doi: 10.1016/s0140-6736(84)91224-8. [DOI] [PubMed] [Google Scholar]
  16. Griffin G. E., Organ C. H., Jr The natural history of the perforated duodenal ulcer treated by suture plication. Ann Surg. 1976 Apr;183(4):382–385. doi: 10.1097/00000658-197604000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Havelund T., Oster-Jørgensen E., Eshøj O., Larsen M. L., Lauritsen K. Effects of cisapride on gastroparesis in patients with insulin-dependent diabetes mellitus. A double-blind controlled trial. Acta Med Scand. 1987;222(4):339–343. doi: 10.1111/j.0954-6820.1987.tb10681.x. [DOI] [PubMed] [Google Scholar]
  18. Jian R., Ducrot F., Piedeloup C., Mary J. Y., Najean Y., Bernier J. J. Measurement of gastric emptying in dyspeptic patients: effect of a new gastrokinetic agent (cisapride). Gut. 1985 Apr;26(4):352–358. doi: 10.1136/gut.26.4.352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Jorde R., Burhol P. G. Asymptomatic peptic ulcer disease. Scand J Gastroenterol. 1987 Mar;22(2):129–134. doi: 10.3109/00365528708991869. [DOI] [PubMed] [Google Scholar]
  20. Kerrigan D. D., Read N. W., Houghton L. A., Taylor M. E., Johnson A. G. Disturbed gastroduodenal motility in patients with active and healed duodenal ulceration. Gastroenterology. 1991 Apr;100(4):892–900. doi: 10.1016/0016-5085(91)90261-i. [DOI] [PubMed] [Google Scholar]
  21. Kurata J. H., Koch G. G., Nogawa A. N. Comparison of ranitidine and cimetidine ulcer maintenance therapy. J Clin Gastroenterol. 1987 Dec;9(6):644–650. doi: 10.1097/00004836-198712000-00007. [DOI] [PubMed] [Google Scholar]
  22. Mark J. B. Factors influencing the treatment of perforated duodenal ulcer. Surg Gynecol Obstet. 1969 Aug;129(2):325–330. [PubMed] [Google Scholar]
  23. Moshal M. G. Trials with metoclopramide in duodenal ulceration. Postgrad Med J. 1973 Jul;49 (Suppl 4):suppl 4–4:104. [PubMed] [Google Scholar]
  24. Müller-Lissner S. A., Fraass C. Chronic oral treatment with cisapride decreases high bile salt reflux rates. Am J Gastroenterol. 1986 May;81(5):354–357. [PubMed] [Google Scholar]
  25. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer. 1976 Dec;34(6):585–612. doi: 10.1038/bjc.1976.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Pounder R. E., Williams J. G., Milton-Thompson G. J., Misiewicz J. J. Relief of duodenal ulcer sysmptons by oral metiamide. Br Med J. 1975 May 10;2(5966):307–309. doi: 10.1136/bmj.2.5966.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Silvis S. E. Final report on the United States Multicenter Trial comparing ranitidine to cimetidine as maintenance therapy following healing of duodenal ulcer. J Clin Gastroenterol. 1985 Dec;7(6):482–487. doi: 10.1097/00004836-198512000-00008. [DOI] [PubMed] [Google Scholar]
  29. Silvis S. E. Results of the United States ranitidine maintenance trials. Am J Med. 1984 Nov 19;77(5B):33–38. [PubMed] [Google Scholar]
  30. Sonnenberg A., Müller-Lissner S. A., Vogel E., Schmid P., Gonvers J. J., Peter P., Strohmeyer G., Blum A. L. Predictors of duodenal ulcer healing and relapse. Gastroenterology. 1981 Dec;81(6):1061–1067. [PubMed] [Google Scholar]
  31. Sontag S., Graham D. Y., Belsito A., Weiss J., Farley A., Grunt R., Cohen N., Kinnear D., Davis W., Archambault A. Cimetidine, cigarette smoking, and recurrence of duodenal ulcer. N Engl J Med. 1984 Sep 13;311(11):689–693. doi: 10.1056/NEJM198409133111101. [DOI] [PubMed] [Google Scholar]
  32. Stacher G., Bergmann H., Wiesnagrotzki S., Kiss A., Schneider C., Mittelbach G., Gaupmann G., Höbart J. Intravenous cisapride accelerates delayed gastric emptying and increases antral contraction amplitude in patients with primary anorexia nervosa. Gastroenterology. 1987 Apr;92(4):1000–1006. doi: 10.1016/0016-5085(87)90976-0. [DOI] [PubMed] [Google Scholar]
  33. Stacher G., Gaupmann G., Mittelbach G., Schneider C., Steinringer H., Langer B. Effects of oral cisapride on interdigestive jejunal motor activity, psychomotor function, and side-effect profile in healthy man. Dig Dis Sci. 1987 Nov;32(11):1223–1230. doi: 10.1007/BF01296370. [DOI] [PubMed] [Google Scholar]
  34. Ström M., Berstad A., Bodemar G., Walan A. Results of short- and long-term cimetidine treatment in patients with juxtapyloric ulcers, with special reference to gastric acid and pepsin secretion. Scand J Gastroenterol. 1986 Jun;21(5):521–530. doi: 10.3109/00365528609003094. [DOI] [PubMed] [Google Scholar]
  35. Texter E. C., Jr, Navab F., Mantell G., Berman R. Maintenance therapy of duodenal ulcer with famotidine. A multicenter United States study. Am J Med. 1986 Oct 24;81(4B):25–32. doi: 10.1016/0002-9343(86)90597-8. [DOI] [PubMed] [Google Scholar]
  36. Urbain J. L., Siegel J. A., Debie N. C., Pauwels S. P. Effect of cisapride on gastric emptying in dyspeptic patients. Dig Dis Sci. 1988 Jul;33(7):779–783. doi: 10.1007/BF01550963. [DOI] [PubMed] [Google Scholar]
  37. Van Deventer G. M., Elashoff J. D., Reedy T. J., Schneidman D., Walsh J. H. A randomized study of maintenance therapy with ranitidine to prevent the recurrence of duodenal ulcer. N Engl J Med. 1989 Apr 27;320(17):1113–1119. doi: 10.1056/NEJM198904273201704. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES